货号：UP297135433
| 产品信息 | |
| 产品名称： | BAPTA |
| 中文名称： | 1,2-双(2-氨基苯氧基)乙烷-N,N,N',N'-四乙酸(请以英文为准,中文仅做参考) |
| CAS号： | 85233-19-8 |
| 分子式： | C22H24N2O10 |
| 分子量： | 476.43 |
| MDL NO： | MFCD00036255 |
| 标准纯度： | 97% (UP297135433) |
| 沸点： | 766.6°C at 760 mmHg |
| 储存： | Sealed in dry,2-8°C (UP297135433) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
(R)-Flurbiprofen
UP35022607251543-40-9
LY2801653
UP5546253841206799-15-6
Methyl 4-(difluoromethoxy)-3-hydroxybenzoate
UP2929448731159429-52-3
(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
UP753689032143527-70-2
Salsalate
UP480575525552-94-3
Histamine phosphate
UP97737949151-74-1
S49076
UP7673069451265965-22-7
2-(Carbamoyloxy)-N,N,N-trimethyl-1-propanaminium Chloride
UP602522151590-63-6
Fenbufen
UP80795115836330-85-5
N-Desethyl Sunitinib
UP327760612356068-97-8
(RS)-MCPG
UP458569374146669-29-6
Mutant IDH1 inhibitor
UP9158681161429180-08-4
(2'R,8S,10R,13S,14S)-10,13-Dimethyl-1,8,10,12,13,14,15,16-octahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5
UP48355469695716-71-5
Imeglimin hydrochloride
UP913973895775351-61-6
PU-H 71 Hydrochloride
UP3954607672095432-24-7
Integrin Antagonist 1 hydrochloride
UP2519206351629249-40-6
Betahistine dihydrochloride
UP3193333975579-84-0
BEC Hydrochloride
UP872549001222638-67-7
Meglutol
UP834804889503-49-1
Dorsomorphin
UP399500061866405-64-3
SU 4312
UP1434382005812-07-7
ONO 6818
UP746906263208848-19-5
AZD-1678
UP282783119942137-41-9
LY404039
UP781329763635318-11-5
Fluvastatin sodium
UP75995784893957-55-2
Suprofen
UP35469282140828-46-4
(R)-3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
UP7850646141146629-83-5
Xanomeline oxalate
UP953217931141064-23-5
GW311616
UP509712583198062-54-3
LDC1267
UP9079922771361030-48-9
Ampkinone
UP5926404161233082-79-5
Methyl 2-(diethoxyphosphoryl)acetate
UP7250090321067-74-9
BX471
UP643371424217645-70-0
Ophiopogonin D
UP492686941945619-74-9
Arg-Gly-Asp-Ser
UP64147371991037-65-9
TTNPB
UP51111644871441-28-6
Diphenylgermanium dichloride
UP6560944591613-66-7
CRAC intermediate 2
UP184995606123066-64-8
VU 0361737
UP9718902981161205-04-4
GW441756
UP901663267504433-23-2
2,2-Dimethyl-1,3-cyclopentanedione
UP1803142243883-58-7
Cyclo(RGDyK)
UP649763393250612-42-1
(S)-3-(3-(((3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-1H-benzo[d]azepi
UP6016752101086026-31-4
NPS-1034
UP1603168771221713-92-3
3-Phenyl-1-Propanol
UP488834838122-97-4
BML-284
UP939075737853220-52-7
Acetylcysteine
UP747400921616-91-1
BX471 hydrochloride
UP804806394288262-96-4
Palovarotene
UP370030208410528-02-8
Tempol
UP6109587862226-96-2
Tazarotene
UP597075769118292-40-3
UC-112
UP892282195383392-66-3
PRIMA-1
UP2316726095608-24-2
Apoptozole
UP6872736931054543-47-3
Cyclo(-RGDfK)
UP590379412161552-03-0
Enasidenib
UP6032500911446502-11-9
INCB 3284 dimesylate
UP479892454887401-93-6
Pravastatin sodium
UP33665000881131-70-6
(2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzo
UP114515123817204-32-3
Spiro[4.5]decane-7,9-dione
UP94021489682683-51-0
Ganetespib
UP429601317888216-25-9
BIIB021
UP286314636848695-25-0
BAPTA
UP29713543385233-19-8